Skip to main content
. 2017 May 31;32(2):e22258. doi: 10.1002/jcla.22258

Table 1.

The basic characteristics of GD patients in none‐LD group and LD group

Group None‐LD group (n=79) LD group (n=41) P value
Age 41.6±11.4 38.1±10.9 .328a
Gender
Male 20 11 .858b
Female 59 30
ALT (0~40 U/L) 25.2±6.5 68.4±35.7 <.001a
AST (29~35 U/L) 30.0±7.0 50.5±19.1 <.001a
GGT (3~50 U/L) 37.0±20.1 62.9±27.2 <.001a
TBIL (3.4~17.1 μmol/L) 14.7±5.3 19.9±8.2 <.001a
ALP (40~150 U/L) 127.3±58.7 171.2±57.1 <.001a
TP (60~80 g/L) 60.4±1.8 54.8±5.2 <.001a
ALB (35~55 g/L) 38.7±2.1 33.7±2.9 <.001a
FT3 (3~9 pmol/L) 14.3±6.8 16.8±8.9 .089a
FT4 (9~25 pmol/L) 52.6±20.7 59.6±18.9 .073a
TSH (0.04‐2.5 mIU/L) 0.016±0.003 0.015±0.004 .126a

GD, Graves’ disease; none‐LD group, GD patients without LD were included; LD group, GD patients with LD were included; ALT, Alanine aminotransferase; AST, Aspartate transaminase; GGT: Gamma‐glutamyl transferase; TBIL, Total bilirubin; ALP, Alkaline phosphatase; TP, Total protein; ALB, Serum albumin; FT3, Free triiodothyronine; FT4, Free thyroxine; TSH, thyroid stimulating hormone.

a

Represents that P value was related to none‐LD and LD group and was analyzed by Mann‐Whitney test.

b

Represents that P value was related to none‐LD and LD group and was analyzed by Chi‐square test.